A federal court sitting in New Jersey has just issued an order green-lighting a class action lawsuit against several manufacturers of generic …

The small Connecticut-…

Drugmaker Mylan Pharmaceuticals, Inc. has issued a…

This month, a fourth Indian drug company involved in the manufacture of valsartan and another angiotensin II receptor blockers (ARBs) received an FDA warning letter over NDEA and NDMA found in its…

Aurobindo Pharma USA, Inc. has issued a voluntary recall of three of its sartan-based prescription medications after discovering trace amounts of a carcinogenic substance known as N-…

For the second time in as many weeks, the Food and Drug Administration has notified physicians and patients…

Only a few months ago, government health authorities in Europe and the U.S.…

Last month, the China-based Zhejiang Huahai Pharmaceutical Company informed the European Medicines Agency that one of their products used in the treatment of hypertension, known as…